Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaëtan MacGrogan

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Computer Methods and Programs in Biomedicine|February 22, 2023
Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkersCélestin Bigarré, François Bertucci, Pascal Finetti, et al.
Cancer|April 24, 2007
Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysisMarc Debled, Gaëtan MacGrogan, Véronique Brouste, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Expression profiling in breast carcinoma: new insights on old prognostic factors?Marc Debled, Gaëtan MacGrogan, Isabelle de Mascarel, et al.
JCO Clinical Cancer Informatics|March 28, 2020
Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast CancerChiara Nicolò, Cynthia Périer, Melanie Prague, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2009
Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patientsMarion Fournier, Eberhard Stoeckle, Frédéric Guyon, et al.
Cancer|May 10, 2002
Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomasIsabelle de Mascarel, Gaëtan MacGrogan, Simone Mathoulin-Pélissier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2012
Accuracy of HER2 status determination on breast core-needle biopsies (immunohistochemistry, FISH, CISH and SISH vs FISH)Laurent Arnould, Pascal Roger, Gaëtan Macgrogan, et al.
BMC Medical Research Methodology|March 18, 2010
Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancerCarine A Bellera, Gaëtan MacGrogan, Marc Debled, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 30, 2008
D2-40 in breast cancer: should we detect more vascular emboli?Isabelle de Mascarel, Gaëtan MacGrogan, Marc Debled, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 9, 2008
Prediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendationsFrédéric Chibon, Isabelle de Mascarel, Ghislaine Sierankowski, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Computer Methods and Programs in Biomedicine|February 22, 2023
Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkersCélestin Bigarré, François Bertucci, Pascal Finetti, et al.
Cancer|April 24, 2007
Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysisMarc Debled, Gaëtan MacGrogan, Véronique Brouste, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Expression profiling in breast carcinoma: new insights on old prognostic factors?Marc Debled, Gaëtan MacGrogan, Isabelle de Mascarel, et al.
JCO Clinical Cancer Informatics|March 28, 2020
Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast CancerChiara Nicolò, Cynthia Périer, Melanie Prague, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2009
Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patientsMarion Fournier, Eberhard Stoeckle, Frédéric Guyon, et al.
Cancer|May 10, 2002
Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomasIsabelle de Mascarel, Gaëtan MacGrogan, Simone Mathoulin-Pélissier, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2012
Accuracy of HER2 status determination on breast core-needle biopsies (immunohistochemistry, FISH, CISH and SISH vs FISH)Laurent Arnould, Pascal Roger, Gaëtan Macgrogan, et al.
BMC Medical Research Methodology|March 18, 2010
Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancerCarine A Bellera, Gaëtan MacGrogan, Marc Debled, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 30, 2008
D2-40 in breast cancer: should we detect more vascular emboli?Isabelle de Mascarel, Gaëtan MacGrogan, Marc Debled, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 9, 2008
Prediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendationsFrédéric Chibon, Isabelle de Mascarel, Ghislaine Sierankowski, et al.
Pageof 8